These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 17380318)

  • 1. Proteomic analysis of human vitreous fluid by fluorescence-based difference gel electrophoresis (DIGE): a new strategy for identifying potential candidates in the pathogenesis of proliferative diabetic retinopathy.
    García-Ramírez M; Canals F; Hernández C; Colomé N; Ferrer C; Carrasco E; García-Arumí J; Simó R
    Diabetologia; 2007 Jun; 50(6):1294-303. PubMed ID: 17380318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interphotoreceptor retinoid-binding protein (IRBP) is downregulated at early stages of diabetic retinopathy.
    Garcia-Ramírez M; Hernández C; Villarroel M; Canals F; Alonso MA; Fortuny R; Masmiquel L; Navarro A; García-Arumí J; Simó R
    Diabetologia; 2009 Dec; 52(12):2633-41. PubMed ID: 19823802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevation of apolipoprotein A-I and apolipoprotein H levels in the vitreous fluid and overexpression in the retina of diabetic patients.
    Simó R; Higuera M; García-Ramírez M; Canals F; García-Arumí J; Hernández C
    Arch Ophthalmol; 2008 Aug; 126(8):1076-81. PubMed ID: 18695102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of new pathogenic candidates for diabetic macular edema using fluorescence-based difference gel electrophoresis analysis.
    Hernández C; García-Ramírez M; Colomé N; Corraliza L; García-Pascual L; Casado J; Canals F; Simó R
    Diabetes Metab Res Rev; 2013 Sep; 29(6):499-506. PubMed ID: 23568601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterisation of the vitreous proteome in proliferative diabetic retinopathy.
    Wang H; Feng L; Hu JW; Xie CL; Wang F
    Proteome Sci; 2012 Mar; 10(1):15. PubMed ID: 22390717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythropoietin is expressed in the human retina and it is highly elevated in the vitreous fluid of patients with diabetic macular edema.
    Hernández C; Fonollosa A; García-Ramírez M; Higuera M; Catalán R; Miralles A; García-Arumí J; Simó R
    Diabetes Care; 2006 Sep; 29(9):2028-33. PubMed ID: 16936148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiating vitreous proteomes in proliferative diabetic retinopathy using high-performance liquid chromatography coupled to tandem mass spectrometry.
    Wang H; Feng L; Hu J; Xie C; Wang F
    Exp Eye Res; 2013 Mar; 108():110-9. PubMed ID: 23276812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the vitreous proteome in diabetes without diabetic retinopathy and diabetes with proliferative diabetic retinopathy.
    Gao BB; Chen X; Timothy N; Aiello LP; Feener EP
    J Proteome Res; 2008 Jun; 7(6):2516-25. PubMed ID: 18433156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative proteomics analysis of vitreous body from type 2 diabetic patients with proliferative diabetic retinopathy.
    Li J; Lu Q; Lu P
    BMC Ophthalmol; 2018 Jun; 18(1):151. PubMed ID: 29940965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between ficolin-3 and vascular endothelial growth factor-to-pigment epithelium-derived factor ratio in the vitreous of eyes with proliferative diabetic retinopathy.
    Zheng B; Li T; Chen H; Xu X; Zheng Z
    Am J Ophthalmol; 2011 Dec; 152(6):1039-43. PubMed ID: 21851923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positive association of pigment epithelium-derived factor with total antioxidant capacity in the vitreous fluid of patients with proliferative diabetic retinopathy.
    Yokoi M; Yamagishi S; Saito A; Yoshida Y; Matsui T; Saito W; Hirose S; Ohgami K; Kase M; Ohno S
    Br J Ophthalmol; 2007 Jul; 91(7):885-7. PubMed ID: 17301120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of soluble vascular endothelial growth factor receptor-1 in the vitreous in proliferative diabetic retinopathy.
    Matsunaga N; Chikaraishi Y; Izuta H; Ogata N; Shimazawa M; Matsumura M; Hara H
    Ophthalmology; 2008 Nov; 115(11):1916-22. PubMed ID: 18718666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracellular matrix proteins in epiretinal membranes and in diabetic retinopathy.
    George B; Chen S; Chaudhary V; Gonder J; Chakrabarti S
    Curr Eye Res; 2009 Feb; 34(2):134-44. PubMed ID: 19219685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased D-serine in the aqueous and vitreous humour in patients with proliferative diabetic retinopathy.
    Jiang H; Du J; He T; Qu J; Song Z; Wu S
    Clin Exp Ophthalmol; 2014 Dec; 42(9):841-5. PubMed ID: 24645972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Profiling of vitreous proteomes from proliferative diabetic retinopathy and nondiabetic patients.
    Kim T; Kim SJ; Kim K; Kang UB; Lee C; Park KS; Yu HG; Kim Y
    Proteomics; 2007 Nov; 7(22):4203-15. PubMed ID: 17955474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proliferative and inflammatory factors in the vitreous of patients with proliferative diabetic retinopathy.
    Chernykh VV; Varvarinsky EV; Smirnov EV; Chernykh DV; Trunov AN
    Indian J Ophthalmol; 2015 Jan; 63(1):33-6. PubMed ID: 25686060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imbalanced levels of angiogenic and angiostatic factors in vitreous, plasma and postmortem retinal tissue of patients with proliferative diabetic retinopathy.
    Mohan N; Monickaraj F; Balasubramanyam M; Rema M; Mohan V
    J Diabetes Complications; 2012; 26(5):435-41. PubMed ID: 22699109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Vitreous levels of stromal cell-derived factor-1 and vascular endothelial growth factor in diabetic retinopathy].
    Chen L; Lü L; Li Y; Huang X; Zhang J; Li S
    Yan Ke Xue Bao; 2008 Mar; 24(1):6-8. PubMed ID: 18709948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of retinal laser photocoagulation on the activity of metalloproteinases and the alpha(2)-macroglobulin proteolytic state in the vitreous of eyes with proliferative diabetic retinopathy.
    Sánchez MC; Luna JD; Barcelona PF; Gramajo AL; Juarez PC; Riera CM; Chiabrando GA
    Exp Eye Res; 2007 Nov; 85(5):644-50. PubMed ID: 17826767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatostatin molecular variants in the vitreous fluid: a comparative study between diabetic patients with proliferative diabetic retinopathy and nondiabetic control subjects.
    Hernández C; Carrasco E; Casamitjana R; Deulofeu R; García-Arumí J; Simó R
    Diabetes Care; 2005 Aug; 28(8):1941-7. PubMed ID: 16043736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.